For his contributions amidst the global pandemic, San Miguel Corporation (SMC) president and chief operating officer, Ramon S. Ang, was given the distinction of Lifetime Contributor Award at the Asia CEO Awards 2020
Touted as one of Asia's most prestigious honours in business, the Asia CEO Awards gives credit to all the movers and shakers of the Philippine and Southeast Asian economies. This year, one of our very own, Ramon S. Ang, has been chosen to be the recipient of the Lifetime Contributor Award. This is in conjunction with his visionary leadership and long-term contributions to the country, and most notably includes the magnanimity in his response to the COVID-19 pandemic.
"What other goal is more worthwhile than helping our country and ... making it better?" Ang says. "What kind of Filipinos would we be if we do not show malasakit towards each other in this time of great need?"
Read also: Visionary Leader Ramon Ang Talks About The Legacy He Would Like To Leave Behind
COVID-19 Response
Ang, who is the San Miguel Corporation (SMC) president and chief operating officer (COO) has been at the helm of a massive outreach program that has amassed over Php13.180 billion in aid. With the help of employees, volunteers, and partner non-profits, SMC has initiated numerous projects to help disadvantaged communities, medical front liners, and even government sectors.
Its COVID-19 response contributions include hundreds of millions in food and medical equipment donations, as well as funding for the government's Libre Sakay program. They have also spearheaded blood donation drives and the construction of temporary quarantine facilities.
Pivoting their business to heed the call of times, SMC had made headlines for repurposing liquor plants to manufacture alcohol instead. They have upped the country's overall testing capacity through distributions of RT-PCR machines and test kits and have recently announced the creation of the RSA Foundation, with which they hope to build a state-of-the-art hospital specialising in infectious disease research.